Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
Heron Therapeutics (HRTX) - Cash on Hand
Cash on Hand as of December 2023 : $80.4 M
According to Heron Therapeutics's latest financial reports the company has $80.4 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Heron Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $80.4 M | -5.24% |
| 2022-12-31 | $84.85 M | -46.15% |
| 2021-12-31 | $0.15 B | -24.42% |
| 2020-12-31 | $0.20 B | -46.67% |
| 2019-12-31 | $0.39 B | 17.63% |
| 2018-12-31 | $0.33 B | 92.81% |
| 2017-12-31 | $0.17 B | 237.09% |
| 2016-12-31 | $51.13 M | -61.01% |
| 2015-12-31 | $0.13 B | 80.48% |
| 2014-12-31 | $72.67 M | 0.54% |
| 2013-12-31 | $72.28 M | 35.1% |
| 2012-12-31 | $53.5 M | 197.69% |
| 2011-12-31 | $17.97 M | 752.25% |
| 2010-12-31 | $2.1 M | -72.22% |
| 2009-12-31 | $7.59 M | -27.95% |
| 2008-12-31 | $10.53 M | -69.94% |
| 2007-12-31 | $35.06 M | 125.89% |
| 2006-12-31 | $15.52 M | 167.21% |
| 2005-12-31 | $5.8 M | -57.27% |
| 2004-12-31 | $13.59 M | 43.36% |
| 2003-12-31 | $9.48 M | -32.84% |
| 2002-12-31 | $14.12 M | -27.56% |
| 2001-12-31 | $19.49 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $35.17 M | -56.26% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $0.27 B | 246.45% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.17 B | 111.80% | 🇺🇸 USA |
 Alkermes ALKS | $0.77 B | 861.95% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.30 B | 277.59% | 🇺🇸 USA |